Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2017-11-16 Board/Management Inform…
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Orphazyme A/S: Election of new members of the Board of Directors
Board/Management Information Classification · 100% confidence The document is an official company announcement regarding the election of new members to the Board of Directors following an extraordinary general meeting. It details the specific individuals joining the board, their backgrounds, and the resulting composition of the board committees. This falls directly under the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors.
2017-11-16 English
Share Issue/Capital Change 2017
Share Issue/Capital Change Classification · 99% confidence The document is an announcement from Orphazyme A/S dated November 14, 2017, regarding the 'Early close of offering of shares in Orphazyme'. It explicitly references an 'offering circular' published in connection with an 'initial public offering' (IPO) and admission to trading on Nasdaq Copenhagen. The content details the closing times for retail and institutional investors and mentions the expected announcement of the offer price and allocation. This clearly relates to fundraising and capital structure changes associated with an IPO, which aligns best with the 'Capital/Financing Update' category.
2017-11-14 English
Early close of offering of shares in Orphazyme
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the early closure of an initial public offering (IPO) of shares for Orphazyme A/S. It details the timing of the offering closure for retail and institutional investors due to high demand. While it relates to capital raising, it is specifically an announcement of the offering process status rather than a standalone financial report or a prospectus itself. Given the nature of the announcement regarding share offerings and capital structure changes, it fits best under the 'SHA' (Share Issue/Capital Change) category, as it pertains to the issuance and offering of new shares.
2017-11-14 English
Godkendelse af prospekt for ORPHAZYME ApS , Aktier, 06.11.2017
Capital/Financing Update Classification · 95% confidence The document is an 'Offering Circular' for Orphazyme A/S, which is a formal prospectus detailing an initial public offering (IPO) of shares. It includes sections on risk factors, business overview, financial information, and the terms of the offering. In the context of financial filings, a prospectus for an IPO is a primary capital-raising document. Among the provided categories, 'Capital/Financing Update' (CAP) is the most appropriate classification for documents detailing share offerings, capital structure changes, and fundraising activities.
2017-11-06 English
Capital/Financing Update 2017
Capital/Financing Update Classification · 98% confidence The document is an official company announcement from Orphazyme A/S dated November 6, 2017. The headline explicitly states: "Orphazyme publishes offering circular and the indicative offer price range for its IPO". The text details the terms of the Initial Public Offering (IPO), including the indicative price range (DKK 64 to DKK 80 per share), the expected market capitalization, the number of new shares to be issued, the offer period, and expected listing dates on Nasdaq Copenhagen. It also mentions the publication of the 'offering circular'. Since this document is the announcement detailing the terms and launch of a financing/capital event (the IPO) and the associated offering circular, it falls under the category for Capital/Financing Updates (CAP). It is not the full 10-K, a quarterly report (IR), or just a simple dividend notice (DIV). It is a specific announcement about raising capital.
2017-11-06 English
Orphazyme publishes offering circular and the indicative offer price range for its IPO
Capital/Financing Update Classification · 95% confidence The document is a formal company announcement regarding an Initial Public Offering (IPO). It details the publication of an offering circular, the indicative price range, the offering structure, and the timeline for the IPO on Nasdaq Copenhagen. While it discusses the offering, it is an announcement of the event and the availability of the circular, rather than the circular itself. Given the nature of the document as a formal regulatory announcement regarding a capital market event (IPO), it fits best under 'Capital/Financing Update'.
2017-11-06 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.